#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Discussion
1-1	0-2	4.	_	_	_	_
1-2	3-13	Discussion	abstract	new	_	_

#Text=Renewed focus on functional and quality of life outcomes after surgery for DCM in adults has come from rigorous scrutiny of the results of several large-scale studies in the last decade .
2-1	14-21	Renewed	abstract[2]	new[2]	coref	4-30[30_2]
2-2	22-27	focus	abstract[2]	new[2]	_	_
2-3	28-30	on	abstract[2]	new[2]	_	_
2-4	31-41	functional	abstract[2]|abstract[4]	new[2]|new[4]	coref	2-22[9_4]
2-5	42-45	and	abstract[2]|abstract[4]	new[2]|new[4]	_	_
2-6	46-53	quality	abstract[2]|abstract[4]	new[2]|new[4]	_	_
2-7	54-56	of	abstract[2]|abstract[4]	new[2]|new[4]	_	_
2-8	57-61	life	abstract[2]|abstract|abstract[4]	new[2]|new|new[4]	coref	3-37
2-9	62-70	outcomes	abstract[2]|abstract[4]	new[2]|new[4]	_	_
2-10	71-76	after	abstract[2]|abstract[4]	new[2]|new[4]	_	_
2-11	77-84	surgery	abstract[2]|abstract[4]|event	new[2]|new[4]|new	coref	3-8
2-12	85-88	for	abstract[2]|abstract[4]	new[2]|new[4]	_	_
2-13	89-92	DCM	abstract[2]|abstract[4]|abstract	new[2]|new[4]|new	coref	5-15
2-14	93-95	in	abstract[2]	new[2]	_	_
2-15	96-102	adults	abstract[2]|person	new[2]|new	coref	11-23[86_0]
2-16	103-106	has	_	_	_	_
2-17	107-111	come	_	_	_	_
2-18	112-116	from	_	_	_	_
2-19	117-125	rigorous	abstract[8]	new[8]	_	_
2-20	126-134	scrutiny	abstract[8]	new[8]	_	_
2-21	135-137	of	abstract[8]	new[8]	_	_
2-22	138-141	the	abstract[8]|abstract[9]	new[8]|giv[9]	coref	5-10[34_9]
2-23	142-149	results	abstract[8]|abstract[9]	new[8]|giv[9]	_	_
2-24	150-152	of	abstract[8]|abstract[9]	new[8]|giv[9]	_	_
2-25	153-160	several	abstract[8]|abstract[9]|abstract[10]	new[8]|giv[9]|new[10]	coref	4-33[31_10]
2-26	161-172	large-scale	abstract[8]|abstract[9]|abstract[10]	new[8]|giv[9]|new[10]	_	_
2-27	173-180	studies	abstract[8]|abstract[9]|abstract[10]	new[8]|giv[9]|new[10]	_	_
2-28	181-183	in	abstract[8]|abstract[9]|abstract[10]	new[8]|giv[9]|new[10]	_	_
2-29	184-187	the	abstract[8]|abstract[9]|abstract[10]|time[11]	new[8]|giv[9]|new[10]|new[11]	_	_
2-30	188-192	last	abstract[8]|abstract[9]|abstract[10]|time[11]	new[8]|giv[9]|new[10]|new[11]	_	_
2-31	193-199	decade	abstract[8]|abstract[9]|abstract[10]|time[11]	new[8]|giv[9]|new[10]|new[11]	_	_
2-32	200-201	.	_	_	_	_

#Text=The traditional doctrine of the use of surgery to ‘ arrest clinical progression ’ has been replaced with a more modern approach with decompressive surgery used as a means to provide both functional and quality of life improvement .
3-1	202-205	The	abstract[12]	new[12]	_	_
3-2	206-217	traditional	abstract[12]	new[12]	_	_
3-3	218-226	doctrine	abstract[12]	new[12]	_	_
3-4	227-229	of	abstract[12]	new[12]	_	_
3-5	230-233	the	abstract[12]|event[13]	new[12]|new[13]	_	_
3-6	234-237	use	abstract[12]|event[13]	new[12]|new[13]	_	_
3-7	238-240	of	abstract[12]|event[13]	new[12]|new[13]	_	_
3-8	241-248	surgery	abstract[12]|event[13]|event	new[12]|new[13]|giv	coref	3-24[17_0]
3-9	249-251	to	abstract[12]|event[13]	new[12]|new[13]	_	_
3-10	252-253	‘	abstract[12]|event[13]	new[12]|new[13]	_	_
3-11	254-260	arrest	abstract[12]|event[13]	new[12]|new[13]	_	_
3-12	261-269	clinical	abstract[12]|event[13]|event[15]	new[12]|new[13]|new[15]	_	_
3-13	270-281	progression	abstract[12]|event[13]|event[15]	new[12]|new[13]|new[15]	_	_
3-14	282-283	’	abstract[12]|event[13]	new[12]|new[13]	_	_
3-15	284-287	has	_	_	_	_
3-16	288-292	been	_	_	_	_
3-17	293-301	replaced	_	_	_	_
3-18	302-306	with	_	_	_	_
3-19	307-308	a	abstract[16]	new[16]	_	_
3-20	309-313	more	abstract[16]	new[16]	_	_
3-21	314-320	modern	abstract[16]	new[16]	_	_
3-22	321-329	approach	abstract[16]	new[16]	_	_
3-23	330-334	with	abstract[16]	new[16]	_	_
3-24	335-348	decompressive	abstract[16]|event[17]	new[16]|giv[17]	coref	5-13[35_17]
3-25	349-356	surgery	abstract[16]|event[17]	new[16]|giv[17]	_	_
3-26	357-361	used	abstract[16]|event[17]	new[16]|giv[17]	_	_
3-27	362-364	as	abstract[16]|event[17]	new[16]|giv[17]	_	_
3-28	365-366	a	abstract[16]|event[17]|abstract[18]	new[16]|giv[17]|new[18]	_	_
3-29	367-372	means	abstract[16]|event[17]|abstract[18]	new[16]|giv[17]|new[18]	_	_
3-30	373-375	to	abstract[16]|event[17]|abstract[18]	new[16]|giv[17]|new[18]	_	_
3-31	376-383	provide	abstract[16]|event[17]|abstract[18]	new[16]|giv[17]|new[18]	_	_
3-32	384-388	both	abstract[16]|event[17]|abstract[18]|abstract[20]	new[16]|giv[17]|new[18]|new[20]	coref	19-17[139_20]
3-33	389-399	functional	abstract[16]|event[17]|abstract[18]|abstract[20]	new[16]|giv[17]|new[18]|new[20]	_	_
3-34	400-403	and	abstract[16]|event[17]|abstract[18]|abstract[20]	new[16]|giv[17]|new[18]|new[20]	_	_
3-35	404-411	quality	abstract[16]|event[17]|abstract[18]|abstract[20]	new[16]|giv[17]|new[18]|new[20]	_	_
3-36	412-414	of	abstract[16]|event[17]|abstract[18]|abstract[20]	new[16]|giv[17]|new[18]|new[20]	_	_
3-37	415-419	life	abstract[16]|event[17]|abstract[18]|abstract|abstract[20]	new[16]|giv[17]|new[18]|giv|new[20]	coref	4-6
3-38	420-431	improvement	abstract[16]|event[17]|abstract[18]|abstract[20]	new[16]|giv[17]|new[18]|new[20]	_	_
3-39	432-433	.	_	_	_	_

#Text=The assessment of quality of life metrics has become particularly important in the examination of patients with mild functional impairment ( or asymptomatic cord compression ) , and is the focus of a number of studies .
4-1	434-437	The	abstract[21]	new[21]	coref	21-26[155_21]
4-2	438-448	assessment	abstract[21]	new[21]	_	_
4-3	449-451	of	abstract[21]	new[21]	_	_
4-4	452-459	quality	abstract[21]|abstract[22]|abstract[24]	new[21]|new[22]|new[24]	coref|coref	11-35[89_22]|24-1[187_24]
4-5	460-462	of	abstract[21]|abstract[22]|abstract[24]	new[21]|new[22]|new[24]	_	_
4-6	463-467	life	abstract[21]|abstract[22]|abstract|abstract[24]	new[21]|new[22]|giv|new[24]	coref	11-37
4-7	468-475	metrics	abstract[21]|abstract[24]	new[21]|new[24]	_	_
4-8	476-479	has	_	_	_	_
4-9	480-486	become	_	_	_	_
4-10	487-499	particularly	_	_	_	_
4-11	500-509	important	_	_	_	_
4-12	510-512	in	_	_	_	_
4-13	513-516	the	abstract[25]	new[25]	_	_
4-14	517-528	examination	abstract[25]	new[25]	_	_
4-15	529-531	of	abstract[25]	new[25]	_	_
4-16	532-540	patients	abstract[25]|person[26]	new[25]|new[26]	coref	7-3[53_26]
4-17	541-545	with	abstract[25]|person[26]	new[25]|new[26]	_	_
4-18	546-550	mild	abstract[25]|person[26]|abstract[27]	new[25]|new[26]|new[27]	coref	5-21[0_27]
4-19	551-561	functional	abstract[25]|person[26]|abstract[27]	new[25]|new[26]|new[27]	_	_
4-20	562-572	impairment	abstract[25]|person[26]|abstract[27]	new[25]|new[26]|new[27]	_	_
4-21	573-574	(	abstract[25]|person[26]	new[25]|new[26]	_	_
4-22	575-577	or	abstract[25]|person[26]	new[25]|new[26]	_	_
4-23	578-590	asymptomatic	abstract[25]|person[26]|abstract[29]	new[25]|new[26]|new[29]	_	_
4-24	591-595	cord	abstract[25]|person[26]|object|abstract[29]	new[25]|new[26]|new|new[29]	_	_
4-25	596-607	compression	abstract[25]|person[26]|abstract[29]	new[25]|new[26]|new[29]	_	_
4-26	608-609	)	abstract[25]|person[26]	new[25]|new[26]	_	_
4-27	610-611	,	_	_	_	_
4-28	612-615	and	_	_	_	_
4-29	616-618	is	_	_	_	_
4-30	619-622	the	abstract[30]	giv[30]	_	_
4-31	623-628	focus	abstract[30]	giv[30]	_	_
4-32	629-631	of	abstract[30]	giv[30]	_	_
4-33	632-633	a	abstract[30]|abstract[31]	giv[30]|giv[31]	coref	6-9[48_31]
4-34	634-640	number	abstract[30]|abstract[31]	giv[30]|giv[31]	_	_
4-35	641-643	of	abstract[30]|abstract[31]	giv[30]|giv[31]	_	_
4-36	644-651	studies	abstract[30]|abstract[31]	giv[30]|giv[31]	_	_
4-37	652-653	.	_	_	_	_

#Text=Careful evaluation has discovered a number of predictors of clinical outcomes from surgery for DCM , including baseline severity of impairment , duration of symptoms , presence of systemic or psychological co-morbidities , obesity , and of course age .
5-1	654-661	Careful	abstract[32]	new[32]	_	_
5-2	662-672	evaluation	abstract[32]	new[32]	_	_
5-3	673-676	has	_	_	_	_
5-4	677-687	discovered	_	_	_	_
5-5	688-689	a	abstract[33]	new[33]	_	_
5-6	690-696	number	abstract[33]	new[33]	_	_
5-7	697-699	of	abstract[33]	new[33]	_	_
5-8	700-710	predictors	abstract[33]	new[33]	_	_
5-9	711-713	of	abstract[33]	new[33]	_	_
5-10	714-722	clinical	abstract[33]|abstract[34]	new[33]|giv[34]	coref	6-13[49_34]
5-11	723-731	outcomes	abstract[33]|abstract[34]	new[33]|giv[34]	_	_
5-12	732-736	from	abstract[33]|abstract[34]	new[33]|giv[34]	_	_
5-13	737-744	surgery	abstract[33]|abstract[34]|event[35]	new[33]|giv[34]|giv[35]	coref	6-22[51_35]
5-14	745-748	for	abstract[33]|abstract[34]|event[35]	new[33]|giv[34]|giv[35]	_	_
5-15	749-752	DCM	abstract[33]|abstract[34]|event[35]|abstract	new[33]|giv[34]|giv[35]|giv	coref	6-24
5-16	753-754	,	abstract[33]	new[33]	_	_
5-17	755-764	including	abstract[33]	new[33]	_	_
5-18	765-773	baseline	abstract[33]|abstract[37]	new[33]|new[37]	_	_
5-19	774-782	severity	abstract[33]|abstract[37]	new[33]|new[37]	_	_
5-20	783-785	of	abstract[33]|abstract[37]	new[33]|new[37]	_	_
5-21	786-796	impairment	abstract[33]|abstract[37]|abstract	new[33]|new[37]|giv	coref	11-20[85_0]
5-22	797-798	,	abstract[33]	new[33]	_	_
5-23	799-807	duration	abstract[33]|time[39]	new[33]|new[39]	coref	7-8[54_39]
5-24	808-810	of	abstract[33]|time[39]	new[33]|new[39]	_	_
5-25	811-819	symptoms	abstract[33]|time[39]|abstract	new[33]|new[39]|new	coref	7-14
5-26	820-821	,	abstract[33]	new[33]	_	_
5-27	822-830	presence	abstract[33]|abstract[41]	new[33]|new[41]	_	_
5-28	831-833	of	abstract[33]|abstract[41]	new[33]|new[41]	_	_
5-29	834-842	systemic	abstract[33]|abstract[41]|abstract[42]	new[33]|new[41]|new[42]	coref	7-21[0_42]
5-30	843-845	or	abstract[33]|abstract[41]|abstract[42]	new[33]|new[41]|new[42]	_	_
5-31	846-859	psychological	abstract[33]|abstract[41]|abstract[42]	new[33]|new[41]|new[42]	_	_
5-32	860-874	co-morbidities	abstract[33]|abstract[41]|abstract[42]	new[33]|new[41]|new[42]	_	_
5-33	875-876	,	abstract[33]	new[33]	_	_
5-34	877-884	obesity	abstract[33]|abstract	new[33]|new	_	_
5-35	885-886	,	abstract[33]	new[33]	_	_
5-36	887-890	and	abstract[33]	new[33]	_	_
5-37	891-893	of	abstract[33]	new[33]	_	_
5-38	894-900	course	abstract[33]	new[33]	_	_
5-39	901-904	age	abstract[33]|abstract	new[33]|new	coref	6-19[50_0]
5-40	905-906	.	_	_	_	_

#Text=With simple univariate analysis of outcome measures , many studies have reported worse functional and QOL outcomes with increasing age after surgery for DCM .
6-1	907-911	With	_	_	_	_
6-2	912-918	simple	abstract[45]	new[45]	_	_
6-3	919-929	univariate	abstract[45]	new[45]	_	_
6-4	930-938	analysis	abstract[45]	new[45]	_	_
6-5	939-941	of	abstract[45]	new[45]	_	_
6-6	942-949	outcome	abstract[45]|abstract|abstract[47]	new[45]|new|new[47]	_	_
6-7	950-958	measures	abstract[45]|abstract[47]	new[45]|new[47]	_	_
6-8	959-960	,	_	_	_	_
6-9	961-965	many	abstract[48]	giv[48]	coref	20-13[147_48]
6-10	966-973	studies	abstract[48]	giv[48]	_	_
6-11	974-978	have	_	_	_	_
6-12	979-987	reported	_	_	_	_
6-13	988-993	worse	abstract[49]	giv[49]	coref	25-15[204_49]
6-14	994-1004	functional	abstract[49]	giv[49]	_	_
6-15	1005-1008	and	abstract[49]	giv[49]	_	_
6-16	1009-1012	QOL	abstract[49]	giv[49]	_	_
6-17	1013-1021	outcomes	abstract[49]	giv[49]	_	_
6-18	1022-1026	with	abstract[49]	giv[49]	_	_
6-19	1027-1037	increasing	abstract[49]|abstract[50]	giv[49]|giv[50]	coref	13-9[96_50]
6-20	1038-1041	age	abstract[49]|abstract[50]	giv[49]|giv[50]	_	_
6-21	1042-1047	after	abstract[49]|abstract[50]	giv[49]|giv[50]	_	_
6-22	1048-1055	surgery	abstract[49]|abstract[50]|event[51]	giv[49]|giv[50]|giv[51]	coref	17-13[0_51]
6-23	1056-1059	for	abstract[49]|abstract[50]|event[51]	giv[49]|giv[50]|giv[51]	_	_
6-24	1060-1063	DCM	abstract[49]|abstract[50]|event[51]|abstract	giv[49]|giv[50]|giv[51]|giv	coref	9-1
6-25	1064-1065	.	_	_	_	_

#Text=However , elderly patients often present with increased duration and worse severity of symptoms , with an increased incidence of co-morbidities .
7-1	1066-1073	However	_	_	_	_
7-2	1074-1075	,	_	_	_	_
7-3	1076-1083	elderly	person[53]	giv[53]	coref	8-1[59_53]
7-4	1084-1092	patients	person[53]	giv[53]	_	_
7-5	1093-1098	often	_	_	_	_
7-6	1099-1106	present	_	_	_	_
7-7	1107-1111	with	_	_	_	_
7-8	1112-1121	increased	time[54]	giv[54]	_	_
7-9	1122-1130	duration	time[54]	giv[54]	_	_
7-10	1131-1134	and	_	_	_	_
7-11	1135-1140	worse	abstract[55]	new[55]	_	_
7-12	1141-1149	severity	abstract[55]	new[55]	_	_
7-13	1150-1152	of	abstract[55]	new[55]	_	_
7-14	1153-1161	symptoms	abstract[55]|abstract	new[55]|giv	coref	11-11
7-15	1162-1163	,	_	_	_	_
7-16	1164-1168	with	_	_	_	_
7-17	1169-1171	an	abstract[57]	new[57]	_	_
7-18	1172-1181	increased	abstract[57]	new[57]	_	_
7-19	1182-1191	incidence	abstract[57]	new[57]	_	_
7-20	1192-1194	of	abstract[57]	new[57]	_	_
7-21	1195-1209	co-morbidities	abstract[57]|abstract	new[57]|giv	coref	11-7
7-22	1210-1211	.	_	_	_	_

#Text=Many elderly patients also present a high , sometimes unacceptable , surgical risk profile that makes decisions regarding surgical management less appropriate .
8-1	1212-1216	Many	person[59]	giv[59]	coref	14-3[101_59]
8-2	1217-1224	elderly	person[59]	giv[59]	_	_
8-3	1225-1233	patients	person[59]	giv[59]	_	_
8-4	1234-1238	also	_	_	_	_
8-5	1239-1246	present	_	_	_	_
8-6	1247-1248	a	abstract[61]	new[61]	_	_
8-7	1249-1253	high	abstract[61]	new[61]	_	_
8-8	1254-1255	,	abstract[61]	new[61]	_	_
8-9	1256-1265	sometimes	abstract[61]	new[61]	_	_
8-10	1266-1278	unacceptable	abstract[61]	new[61]	_	_
8-11	1279-1280	,	abstract[61]	new[61]	_	_
8-12	1281-1289	surgical	abstract[60]|abstract[61]	new[60]|new[61]	_	_
8-13	1290-1294	risk	abstract[60]|abstract[61]	new[60]|new[61]	_	_
8-14	1295-1302	profile	abstract[61]	new[61]	_	_
8-15	1303-1307	that	abstract[61]	new[61]	_	_
8-16	1308-1313	makes	abstract[61]	new[61]	_	_
8-17	1314-1323	decisions	abstract[61]|abstract[62]	new[61]|new[62]	_	_
8-18	1324-1333	regarding	abstract[61]|abstract[62]	new[61]|new[62]	_	_
8-19	1334-1342	surgical	abstract[61]|abstract[62]|abstract[63]	new[61]|new[62]|new[63]	_	_
8-20	1343-1353	management	abstract[61]|abstract[62]|abstract[63]	new[61]|new[62]|new[63]	_	_
8-21	1354-1358	less	abstract[61]	new[61]	_	_
8-22	1359-1370	appropriate	abstract[61]	new[61]	_	_
8-23	1371-1372	.	_	_	_	_

#Text=DCM is a disease that can cause a significant amount of potentially reversible or preventable neurological disability in the elderly population , and therefore concerted efforts should be made to improve decision-making strategies for this patient group .
9-1	1373-1376	DCM	abstract	giv	coref	9-3[65_0]
9-2	1377-1379	is	_	_	_	_
9-3	1380-1381	a	abstract[65]	giv[65]	coref	13-16[0_65]
9-4	1382-1389	disease	abstract[65]	giv[65]	_	_
9-5	1390-1394	that	abstract[65]	giv[65]	_	_
9-6	1395-1398	can	abstract[65]	giv[65]	_	_
9-7	1399-1404	cause	abstract[65]	giv[65]	_	_
9-8	1405-1406	a	abstract[65]|abstract[66]	giv[65]|new[66]	_	_
9-9	1407-1418	significant	abstract[65]|abstract[66]	giv[65]|new[66]	_	_
9-10	1419-1425	amount	abstract[65]|abstract[66]	giv[65]|new[66]	_	_
9-11	1426-1428	of	abstract[65]|abstract[66]	giv[65]|new[66]	_	_
9-12	1429-1440	potentially	abstract[65]|abstract[66]|abstract[67]	giv[65]|new[66]|new[67]	coref	22-4[0_67]
9-13	1441-1451	reversible	abstract[65]|abstract[66]|abstract[67]	giv[65]|new[66]|new[67]	_	_
9-14	1452-1454	or	abstract[65]|abstract[66]|abstract[67]	giv[65]|new[66]|new[67]	_	_
9-15	1455-1466	preventable	abstract[65]|abstract[66]|abstract[67]	giv[65]|new[66]|new[67]	_	_
9-16	1467-1479	neurological	abstract[65]|abstract[66]|abstract[67]	giv[65]|new[66]|new[67]	_	_
9-17	1480-1490	disability	abstract[65]|abstract[66]|abstract[67]	giv[65]|new[66]|new[67]	_	_
9-18	1491-1493	in	abstract[65]|abstract[66]|abstract[67]	giv[65]|new[66]|new[67]	_	_
9-19	1494-1497	the	abstract[65]|abstract[66]|abstract[67]|person[68]	giv[65]|new[66]|new[67]|new[68]	_	_
9-20	1498-1505	elderly	abstract[65]|abstract[66]|abstract[67]|person[68]	giv[65]|new[66]|new[67]|new[68]	_	_
9-21	1506-1516	population	abstract[65]|abstract[66]|abstract[67]|person[68]	giv[65]|new[66]|new[67]|new[68]	_	_
9-22	1517-1518	,	_	_	_	_
9-23	1519-1522	and	_	_	_	_
9-24	1523-1532	therefore	_	_	_	_
9-25	1533-1542	concerted	abstract[69]	new[69]	_	_
9-26	1543-1550	efforts	abstract[69]	new[69]	_	_
9-27	1551-1557	should	_	_	_	_
9-28	1558-1560	be	_	_	_	_
9-29	1561-1565	made	_	_	_	_
9-30	1566-1568	to	_	_	_	_
9-31	1569-1576	improve	_	_	_	_
9-32	1577-1592	decision-making	abstract|abstract[71]	new|new[71]	_	_
9-33	1593-1603	strategies	abstract[71]	new[71]	_	_
9-34	1604-1607	for	abstract[71]	new[71]	_	_
9-35	1608-1612	this	abstract[71]|person[72]	new[71]|new[72]	coref	23-24[183_72]
9-36	1613-1620	patient	abstract[71]|person[72]	new[71]|new[72]	_	_
9-37	1621-1626	group	abstract[71]|person[72]	new[71]|new[72]	_	_
9-38	1627-1628	.	_	_	_	_

#Text=The results of the current study demonstrate a number of important conclusions , some of which have not been described in previous literature .
10-1	1629-1632	The	abstract[73]	new[73]	_	_
10-2	1633-1640	results	abstract[73]	new[73]	_	_
10-3	1641-1643	of	abstract[73]	new[73]	_	_
10-4	1644-1647	the	abstract[73]|abstract[74]	new[73]|new[74]	coref	18-8[133_74]
10-5	1648-1655	current	abstract[73]|abstract[74]	new[73]|new[74]	_	_
10-6	1656-1661	study	abstract[73]|abstract[74]	new[73]|new[74]	_	_
10-7	1662-1673	demonstrate	_	_	_	_
10-8	1674-1675	a	abstract[75]	new[75]	_	_
10-9	1676-1682	number	abstract[75]	new[75]	_	_
10-10	1683-1685	of	abstract[75]	new[75]	_	_
10-11	1686-1695	important	abstract[75]	new[75]	_	_
10-12	1696-1707	conclusions	abstract[75]	new[75]	_	_
10-13	1708-1709	,	abstract[75]	new[75]	_	_
10-14	1710-1714	some	abstract[75]	new[75]	_	_
10-15	1715-1717	of	abstract[75]	new[75]	_	_
10-16	1718-1723	which	abstract[75]	new[75]	_	_
10-17	1724-1728	have	abstract[75]	new[75]	_	_
10-18	1729-1732	not	abstract[75]	new[75]	_	_
10-19	1733-1737	been	abstract[75]	new[75]	_	_
10-20	1738-1747	described	abstract[75]	new[75]	_	_
10-21	1748-1750	in	abstract[75]	new[75]	_	_
10-22	1751-1759	previous	abstract[75]|abstract[76]	new[75]|new[76]	_	_
10-23	1760-1770	literature	abstract[75]|abstract[76]	new[75]|new[76]	_	_
10-24	1771-1772	.	_	_	_	_

#Text=Firstly , even when matched for co-morbidities , duration of symptoms , sex , smoking status and severity of functional impairment , younger adults report significantly worse effects on their baseline physical and mental quality of life scores compared to the older aged cohort .
11-1	1773-1780	Firstly	_	_	_	_
11-2	1781-1782	,	_	_	_	_
11-3	1783-1787	even	_	_	_	_
11-4	1788-1792	when	_	_	_	_
11-5	1793-1800	matched	_	_	_	_
11-6	1801-1804	for	_	_	_	_
11-7	1805-1819	co-morbidities	abstract|abstract[78]	giv|giv[78]	coref	11-7[78_0]
11-8	1820-1821	,	abstract[78]	giv[78]	_	_
11-9	1822-1830	duration	abstract[78]|time[79]	giv[78]|new[79]	_	_
11-10	1831-1833	of	abstract[78]|time[79]	giv[78]|new[79]	_	_
11-11	1834-1842	symptoms	abstract[78]|time[79]|abstract	giv[78]|new[79]|giv	coref	14-13[104_0]
11-12	1843-1844	,	abstract[78]	giv[78]	_	_
11-13	1845-1848	sex	abstract[78]|abstract	giv[78]|new	_	_
11-14	1849-1850	,	abstract[78]	giv[78]	_	_
11-15	1851-1858	smoking	abstract[78]|abstract|abstract[83]	giv[78]|new|new[83]	_	_
11-16	1859-1865	status	abstract[78]|abstract[83]	giv[78]|new[83]	_	_
11-17	1866-1869	and	abstract[78]	giv[78]	_	_
11-18	1870-1878	severity	abstract[78]|abstract[84]	giv[78]|new[84]	_	_
11-19	1879-1881	of	abstract[78]|abstract[84]	giv[78]|new[84]	_	_
11-20	1882-1892	functional	abstract[78]|abstract[84]|abstract[85]	giv[78]|new[84]|giv[85]	coref	16-5[118_85]
11-21	1893-1903	impairment	abstract[78]|abstract[84]|abstract[85]	giv[78]|new[84]|giv[85]	_	_
11-22	1904-1905	,	_	_	_	_
11-23	1906-1913	younger	person[86]	giv[86]	ana	11-30[0_86]
11-24	1914-1920	adults	person[86]	giv[86]	_	_
11-25	1921-1927	report	_	_	_	_
11-26	1928-1941	significantly	abstract[87]	new[87]	coref	28-3[232_87]
11-27	1942-1947	worse	abstract[87]	new[87]	_	_
11-28	1948-1955	effects	abstract[87]	new[87]	_	_
11-29	1956-1958	on	abstract[87]	new[87]	_	_
11-30	1959-1964	their	abstract[87]|person|abstract[91]	new[87]|giv|new[91]	coref|coref	16-4[119_91]|21-41[160_0]
11-31	1965-1973	baseline	abstract[87]|abstract[91]	new[87]|new[91]	_	_
11-32	1974-1982	physical	abstract[87]|abstract[91]	new[87]|new[91]	_	_
11-33	1983-1986	and	abstract[87]|abstract[91]	new[87]|new[91]	_	_
11-34	1987-1993	mental	abstract[87]|abstract[91]	new[87]|new[91]	_	_
11-35	1994-2001	quality	abstract[87]|abstract[89]|abstract[91]	new[87]|giv[89]|new[91]	coref	25-15[202_89]
11-36	2002-2004	of	abstract[87]|abstract[89]|abstract[91]	new[87]|giv[89]|new[91]	_	_
11-37	2005-2009	life	abstract[87]|abstract[89]|abstract|abstract[91]	new[87]|giv[89]|giv|new[91]	ana	12-1
11-38	2010-2016	scores	abstract[87]|abstract[91]	new[87]|new[91]	_	_
11-39	2017-2025	compared	abstract[87]|abstract[91]	new[87]|new[91]	_	_
11-40	2026-2028	to	abstract[87]|abstract[91]	new[87]|new[91]	_	_
11-41	2029-2032	the	abstract[87]|abstract[91]|person[92]	new[87]|new[91]|new[92]	coref	13-4[95_92]
11-42	2033-2038	older	abstract[87]|abstract[91]|person[92]	new[87]|new[91]|new[92]	_	_
11-43	2039-2043	aged	abstract[87]|abstract[91]|person[92]	new[87]|new[91]|new[92]	_	_
11-44	2044-2050	cohort	abstract[87]|abstract[91]|person[92]	new[87]|new[91]|new[92]	_	_
11-45	2051-2052	.	_	_	_	_

#Text=This could be explained through 2 potential mechanisms .
12-1	2053-2057	This	abstract	giv	coref	14-26
12-2	2058-2063	could	_	_	_	_
12-3	2064-2066	be	_	_	_	_
12-4	2067-2076	explained	_	_	_	_
12-5	2077-2084	through	_	_	_	_
12-6	2085-2086	2	abstract[94]	new[94]	coref	21-1[148_94]
12-7	2087-2096	potential	abstract[94]	new[94]	_	_
12-8	2097-2107	mechanisms	abstract[94]	new[94]	_	_
12-9	2108-2109	.	_	_	_	_

#Text=Firstly , as the younger cohort were of working age , the psychological impact of DCM may be greater if employment security is perceived to be threatened .
13-1	2110-2117	Firstly	_	_	_	_
13-2	2118-2119	,	_	_	_	_
13-3	2120-2122	as	_	_	_	_
13-4	2123-2126	the	person[95]	giv[95]	coref	24-12[189_95]
13-5	2127-2134	younger	person[95]	giv[95]	_	_
13-6	2135-2141	cohort	person[95]	giv[95]	_	_
13-7	2142-2146	were	_	_	_	_
13-8	2147-2149	of	_	_	_	_
13-9	2150-2157	working	abstract[96]	giv[96]	coref	22-28[0_96]
13-10	2158-2161	age	abstract[96]	giv[96]	_	_
13-11	2162-2163	,	_	_	_	_
13-12	2164-2167	the	abstract[97]	new[97]	_	_
13-13	2168-2181	psychological	abstract[97]	new[97]	_	_
13-14	2182-2188	impact	abstract[97]	new[97]	_	_
13-15	2189-2191	of	abstract[97]	new[97]	_	_
13-16	2192-2195	DCM	abstract[97]|abstract	new[97]|giv	coref	14-16
13-17	2196-2199	may	_	_	_	_
13-18	2200-2202	be	_	_	_	_
13-19	2203-2210	greater	_	_	_	_
13-20	2211-2213	if	_	_	_	_
13-21	2214-2224	employment	abstract|abstract[100]	new|new[100]	_	_
13-22	2225-2233	security	abstract[100]	new[100]	_	_
13-23	2234-2236	is	_	_	_	_
13-24	2237-2246	perceived	_	_	_	_
13-25	2247-2249	to	_	_	_	_
13-26	2250-2252	be	_	_	_	_
13-27	2253-2263	threatened	_	_	_	_
13-28	2264-2265	.	_	_	_	_

#Text=Secondly , the elderly patients demonstrate psychological resilience or adaptations/support that mean the symptoms of DCM have a less pronounced effect on their quality of life .
14-1	2266-2274	Secondly	_	_	_	_
14-2	2275-2276	,	_	_	_	_
14-3	2277-2280	the	person[101]	giv[101]	ana	14-23[0_101]
14-4	2281-2288	elderly	person[101]	giv[101]	_	_
14-5	2289-2297	patients	person[101]	giv[101]	_	_
14-6	2298-2309	demonstrate	_	_	_	_
14-7	2310-2323	psychological	abstract[102]	new[102]	_	_
14-8	2324-2334	resilience	abstract[102]	new[102]	_	_
14-9	2335-2337	or	_	_	_	_
14-10	2338-2357	adaptations/support	abstract[103]	new[103]	_	_
14-11	2358-2362	that	abstract[103]	new[103]	_	_
14-12	2363-2367	mean	abstract[103]	new[103]	_	_
14-13	2368-2371	the	abstract[103]|abstract[104]	new[103]|giv[104]	coref	21-18[0_104]
14-14	2372-2380	symptoms	abstract[103]|abstract[104]	new[103]|giv[104]	_	_
14-15	2381-2383	of	abstract[103]|abstract[104]	new[103]|giv[104]	_	_
14-16	2384-2387	DCM	abstract[103]|abstract[104]|abstract	new[103]|giv[104]|giv	coref	15-16
14-17	2388-2392	have	abstract[103]	new[103]	_	_
14-18	2393-2394	a	abstract[103]|abstract[106]	new[103]|new[106]	_	_
14-19	2395-2399	less	abstract[103]|abstract[106]	new[103]|new[106]	_	_
14-20	2400-2410	pronounced	abstract[103]|abstract[106]	new[103]|new[106]	_	_
14-21	2411-2417	effect	abstract[103]|abstract[106]	new[103]|new[106]	_	_
14-22	2418-2420	on	abstract[103]|abstract[106]	new[103]|new[106]	_	_
14-23	2421-2426	their	abstract[103]|abstract[106]|person|abstract[108]	new[103]|new[106]|giv|new[108]	coref	15-15[116_0]
14-24	2427-2434	quality	abstract[103]|abstract[106]|abstract[108]	new[103]|new[106]|new[108]	_	_
14-25	2435-2437	of	abstract[103]|abstract[106]|abstract[108]	new[103]|new[106]|new[108]	_	_
14-26	2438-2442	life	abstract[103]|abstract[106]|abstract[108]|abstract	new[103]|new[106]|new[108]|giv	ana	15-1
14-27	2443-2444	.	_	_	_	_

#Text=This is an interesting concept , and is an important consideration for clinicians managing elderly DCM patients .
15-1	2445-2449	This	abstract	giv	coref	15-3[111_0]
15-2	2450-2452	is	_	_	_	_
15-3	2453-2455	an	abstract[111]|abstract[112]	giv[111]|giv[112]	coref|coref	15-3[112_111]|25-17[0_112]
15-4	2456-2467	interesting	abstract[111]|abstract[112]	giv[111]|giv[112]	_	_
15-5	2468-2475	concept	abstract[111]|abstract[112]	giv[111]|giv[112]	_	_
15-6	2476-2477	,	abstract[112]	giv[112]	_	_
15-7	2478-2481	and	abstract[112]	giv[112]	_	_
15-8	2482-2484	is	abstract[112]	giv[112]	_	_
15-9	2485-2487	an	abstract[112]|abstract[113]	giv[112]|new[113]	_	_
15-10	2488-2497	important	abstract[112]|abstract[113]	giv[112]|new[113]	_	_
15-11	2498-2511	consideration	abstract[112]|abstract[113]	giv[112]|new[113]	_	_
15-12	2512-2515	for	abstract[112]|abstract[113]	giv[112]|new[113]	_	_
15-13	2516-2526	clinicians	abstract[112]|abstract[113]|person[114]	giv[112]|new[113]|new[114]	_	_
15-14	2527-2535	managing	abstract[112]|abstract[113]|person[114]	giv[112]|new[113]|new[114]	_	_
15-15	2536-2543	elderly	abstract[112]|abstract[113]|person[114]|person[116]	giv[112]|new[113]|new[114]|giv[116]	coref	16-1[117_116]
15-16	2544-2547	DCM	abstract[112]|abstract[113]|person[114]|abstract|person[116]	giv[112]|new[113]|new[114]|giv|giv[116]	coref	17-24
15-17	2548-2556	patients	abstract[112]|abstract[113]|person[114]|person[116]	giv[112]|new[113]|new[114]|giv[116]	_	_
15-18	2557-2558	.	_	_	_	_

#Text=All patients showed improved functional impairment scores after 2 years ( see Table 2 ) .
16-1	2559-2562	All	person[117]	giv[117]	coref	17-23[130_117]
16-2	2563-2571	patients	person[117]	giv[117]	_	_
16-3	2572-2578	showed	_	_	_	_
16-4	2579-2587	improved	abstract[119]	giv[119]	coref	19-5[136_119]
16-5	2588-2598	functional	abstract[118]|abstract[119]	giv[118]|giv[119]	_	_
16-6	2599-2609	impairment	abstract[118]|abstract[119]	giv[118]|giv[119]	_	_
16-7	2610-2616	scores	abstract[119]	giv[119]	_	_
16-8	2617-2622	after	_	_	_	_
16-9	2623-2624	2	time[120]	new[120]	coref	19-8[137_120]
16-10	2625-2630	years	time[120]	new[120]	_	_
16-11	2631-2632	(	_	_	_	_
16-12	2633-2636	see	_	_	_	_
16-13	2637-2642	Table	abstract[121]	new[121]	_	_
16-14	2643-2644	2	abstract[121]	new[121]	_	_
16-15	2645-2646	)	_	_	_	_
16-16	2647-2648	.	_	_	_	_

#Text=Taking the older cohort in isolation , this is good evidence that surgery is an effective modality to produce functional improvements in elderly DCM patients .
17-1	2649-2655	Taking	abstract[125]	giv[125]	coref|coref	17-1[125_0]|25-3[199_125]
17-2	2656-2659	the	person[122]|abstract[125]	new[122]|giv[125]	coref	19-33[143_122]
17-3	2660-2665	older	person[122]|abstract[125]	new[122]|giv[125]	_	_
17-4	2666-2672	cohort	person[122]|abstract[125]	new[122]|giv[125]	_	_
17-5	2673-2675	in	abstract[125]	giv[125]	_	_
17-6	2676-2685	isolation	abstract|abstract[125]	new|giv[125]	ana	17-8
17-7	2686-2687	,	abstract[125]	giv[125]	_	_
17-8	2688-2692	this	abstract|abstract[125]	giv|giv[125]	_	_
17-9	2693-2695	is	abstract[125]	giv[125]	_	_
17-10	2696-2700	good	abstract[125]	giv[125]	_	_
17-11	2701-2709	evidence	abstract[125]	giv[125]	_	_
17-12	2710-2714	that	abstract[125]	giv[125]	_	_
17-13	2715-2722	surgery	abstract[125]|event|abstract[127]	giv[125]|giv|new[127]	ana|coref	18-1[0_127]|19-22
17-14	2723-2725	is	abstract[125]|abstract[127]	giv[125]|new[127]	_	_
17-15	2726-2728	an	abstract[125]|abstract[127]	giv[125]|new[127]	_	_
17-16	2729-2738	effective	abstract[125]|abstract[127]	giv[125]|new[127]	_	_
17-17	2739-2747	modality	abstract[125]|abstract[127]	giv[125]|new[127]	_	_
17-18	2748-2750	to	abstract[125]|abstract[127]	giv[125]|new[127]	_	_
17-19	2751-2758	produce	abstract[125]|abstract[127]	giv[125]|new[127]	_	_
17-20	2759-2769	functional	abstract[125]|abstract[127]|abstract[128]	giv[125]|new[127]|new[128]	_	_
17-21	2770-2782	improvements	abstract[125]|abstract[127]|abstract[128]	giv[125]|new[127]|new[128]	_	_
17-22	2783-2785	in	abstract[125]|abstract[127]|abstract[128]	giv[125]|new[127]|new[128]	_	_
17-23	2786-2793	elderly	abstract[125]|abstract[127]|abstract[128]|person[130]	giv[125]|new[127]|new[128]|giv[130]	coref	19-29[142_130]
17-24	2794-2797	DCM	abstract[125]|abstract[127]|abstract[128]|abstract|person[130]	giv[125]|new[127]|new[128]|giv|giv[130]	coref	25-25
17-25	2798-2806	patients	abstract[125]|abstract[127]|abstract[128]|person[130]	giv[125]|new[127]|new[128]|giv[130]	_	_
17-26	2807-2808	.	_	_	_	_

#Text=This is an important stand-alone conclusion from this study .
18-1	2809-2813	This	abstract	giv	coref	18-3[132_0]
18-2	2814-2816	is	_	_	_	_
18-3	2817-2819	an	abstract[132]	giv[132]	coref	20-1[144_132]
18-4	2820-2829	important	abstract[132]	giv[132]	_	_
18-5	2830-2841	stand-alone	abstract[132]	giv[132]	_	_
18-6	2842-2852	conclusion	abstract[132]	giv[132]	_	_
18-7	2853-2857	from	abstract[132]	giv[132]	_	_
18-8	2858-2862	this	abstract[132]|abstract[133]	giv[132]|giv[133]	coref	27-1[220_133]
18-9	2863-2868	study	abstract[132]|abstract[133]	giv[132]|giv[133]	_	_
18-10	2869-2870	.	_	_	_	_

#Text=When the change from baseline scores at 2 years is calculated , it becomes evident that the functional improvement seen after surgery is of a greater magnitude in younger patients compared to the older cohort .
19-1	2871-2875	When	_	_	_	_
19-2	2876-2879	the	event[134]	new[134]	ana	19-13[0_134]
19-3	2880-2886	change	event[134]	new[134]	_	_
19-4	2887-2891	from	event[134]	new[134]	_	_
19-5	2892-2900	baseline	event[134]|abstract|abstract[136]	new[134]|new|giv[136]	coref|coref	23-10|23-20[182_136]
19-6	2901-2907	scores	event[134]|abstract[136]	new[134]|giv[136]	_	_
19-7	2908-2910	at	event[134]	new[134]	_	_
19-8	2911-2912	2	event[134]|time[137]	new[134]|giv[137]	_	_
19-9	2913-2918	years	event[134]|time[137]	new[134]|giv[137]	_	_
19-10	2919-2921	is	_	_	_	_
19-11	2922-2932	calculated	_	_	_	_
19-12	2933-2934	,	_	_	_	_
19-13	2935-2937	it	event	giv	_	_
19-14	2938-2945	becomes	_	_	_	_
19-15	2946-2953	evident	_	_	_	_
19-16	2954-2958	that	_	_	_	_
19-17	2959-2962	the	abstract[139]	giv[139]	coref	24-7[188_139]
19-18	2963-2973	functional	abstract[139]	giv[139]	_	_
19-19	2974-2985	improvement	abstract[139]	giv[139]	_	_
19-20	2986-2990	seen	abstract[139]	giv[139]	_	_
19-21	2991-2996	after	abstract[139]	giv[139]	_	_
19-22	2997-3004	surgery	abstract[139]|event	giv[139]|giv	coref	22-14
19-23	3005-3007	is	_	_	_	_
19-24	3008-3010	of	_	_	_	_
19-25	3011-3012	a	abstract[141]	new[141]	ana	20-6[145_141]
19-26	3013-3020	greater	abstract[141]	new[141]	_	_
19-27	3021-3030	magnitude	abstract[141]	new[141]	_	_
19-28	3031-3033	in	abstract[141]	new[141]	_	_
19-29	3034-3041	younger	abstract[141]|person[142]	new[141]|giv[142]	coref	21-10[151_142]
19-30	3042-3050	patients	abstract[141]|person[142]	new[141]|giv[142]	_	_
19-31	3051-3059	compared	abstract[141]	new[141]	_	_
19-32	3060-3062	to	abstract[141]	new[141]	_	_
19-33	3063-3066	the	abstract[141]|person[143]	new[141]|giv[143]	coref	24-26[193_143]
19-34	3067-3072	older	abstract[141]|person[143]	new[141]|giv[143]	_	_
19-35	3073-3079	cohort	abstract[141]|person[143]	new[141]|giv[143]	_	_
19-36	3080-3081	.	_	_	_	_

#Text=This conclusion is similar to those described from previous univariate analyses in prior studies .
20-1	3082-3086	This	abstract[144]	giv[144]	_	_
20-2	3087-3097	conclusion	abstract[144]	giv[144]	_	_
20-3	3098-3100	is	_	_	_	_
20-4	3101-3108	similar	_	_	_	_
20-5	3109-3111	to	_	_	_	_
20-6	3112-3117	those	abstract[145]	giv[145]	coref	22-23[0_145]
20-7	3118-3127	described	abstract[145]	giv[145]	_	_
20-8	3128-3132	from	abstract[145]	giv[145]	_	_
20-9	3133-3141	previous	abstract[145]|abstract[146]	giv[145]|new[146]	_	_
20-10	3142-3152	univariate	abstract[145]|abstract[146]	giv[145]|new[146]	_	_
20-11	3153-3161	analyses	abstract[145]|abstract[146]	giv[145]|new[146]	_	_
20-12	3162-3164	in	abstract[145]|abstract[146]	giv[145]|new[146]	_	_
20-13	3165-3170	prior	abstract[145]|abstract[146]|abstract[147]	giv[145]|new[146]|giv[147]	_	_
20-14	3171-3178	studies	abstract[145]|abstract[146]|abstract[147]	giv[145]|new[146]|giv[147]	_	_
20-15	3179-3180	.	_	_	_	_

#Text=Suggested mechanisms for this discrepancy include the fact that elderly patients often present with increased duration of symptoms at diagnosis , often have difficulty accessing specialist assessment and imaging , and also have less neurological plasticity or reserve compared to younger adults .
21-1	3181-3190	Suggested	abstract[148]	giv[148]	_	_
21-2	3191-3201	mechanisms	abstract[148]	giv[148]	_	_
21-3	3202-3205	for	abstract[148]	giv[148]	_	_
21-4	3206-3210	this	abstract[148]|abstract[149]	giv[148]|new[149]	_	_
21-5	3211-3222	discrepancy	abstract[148]|abstract[149]	giv[148]|new[149]	_	_
21-6	3223-3230	include	_	_	_	_
21-7	3231-3234	the	abstract[150]	new[150]	_	_
21-8	3235-3239	fact	abstract[150]	new[150]	_	_
21-9	3240-3244	that	abstract[150]	new[150]	_	_
21-10	3245-3252	elderly	abstract[150]|person[151]	new[150]|giv[151]	coref	22-16[165_151]
21-11	3253-3261	patients	abstract[150]|person[151]	new[150]|giv[151]	_	_
21-12	3262-3267	often	abstract[150]	new[150]	_	_
21-13	3268-3275	present	abstract[150]	new[150]	_	_
21-14	3276-3280	with	abstract[150]	new[150]	_	_
21-15	3281-3290	increased	abstract[150]|time[152]	new[150]|new[152]	_	_
21-16	3291-3299	duration	abstract[150]|time[152]	new[150]|new[152]	_	_
21-17	3300-3302	of	abstract[150]|time[152]	new[150]|new[152]	_	_
21-18	3303-3311	symptoms	abstract[150]|time[152]|abstract	new[150]|new[152]|giv	_	_
21-19	3312-3314	at	abstract[150]|time[152]	new[150]|new[152]	_	_
21-20	3315-3324	diagnosis	abstract[150]|time[152]|event	new[150]|new[152]|new	_	_
21-21	3325-3326	,	abstract[150]	new[150]	_	_
21-22	3327-3332	often	abstract[150]	new[150]	_	_
21-23	3333-3337	have	abstract[150]	new[150]	_	_
21-24	3338-3348	difficulty	abstract[150]	new[150]	_	_
21-25	3349-3358	accessing	abstract[150]	new[150]	_	_
21-26	3359-3369	specialist	abstract[150]|abstract[155]|abstract[156]	new[150]|giv[155]|new[156]	coref|coref	27-27[227_155]|27-27[228_156]
21-27	3370-3380	assessment	abstract[150]|abstract[155]|abstract[156]	new[150]|giv[155]|new[156]	_	_
21-28	3381-3384	and	abstract[150]|abstract[156]	new[150]|new[156]	_	_
21-29	3385-3392	imaging	abstract[150]|abstract[156]|abstract	new[150]|new[156]|new	_	_
21-30	3393-3394	,	abstract[150]	new[150]	_	_
21-31	3395-3398	and	abstract[150]	new[150]	_	_
21-32	3399-3403	also	abstract[150]	new[150]	_	_
21-33	3404-3408	have	abstract[150]	new[150]	_	_
21-34	3409-3413	less	abstract[150]|abstract[158]	new[150]|new[158]	_	_
21-35	3414-3426	neurological	abstract[150]|abstract[158]	new[150]|new[158]	_	_
21-36	3427-3437	plasticity	abstract[150]|abstract[158]	new[150]|new[158]	_	_
21-37	3438-3440	or	abstract[150]	new[150]	_	_
21-38	3441-3448	reserve	abstract[150]|abstract	new[150]|new	_	_
21-39	3449-3457	compared	_	_	_	_
21-40	3458-3460	to	_	_	_	_
21-41	3461-3468	younger	person[160]	giv[160]	_	_
21-42	3469-3475	adults	person[160]	giv[160]	_	_
21-43	3476-3477	.	_	_	_	_

#Text=The level of disability as measured by the NDI was improved significantly by surgery for all patients , but the order of magnitude was similar for both age groups ( p = 0.094 ) .
22-1	3478-3481	The	abstract[161]	new[161]	_	_
22-2	3482-3487	level	abstract[161]	new[161]	_	_
22-3	3488-3490	of	abstract[161]	new[161]	_	_
22-4	3491-3501	disability	abstract[161]|abstract	new[161]|giv	_	_
22-5	3502-3504	as	abstract[161]	new[161]	_	_
22-6	3505-3513	measured	abstract[161]	new[161]	_	_
22-7	3514-3516	by	abstract[161]	new[161]	_	_
22-8	3517-3520	the	abstract[161]|abstract[163]	new[161]|new[163]	_	_
22-9	3521-3524	NDI	abstract[161]|abstract[163]	new[161]|new[163]	_	_
22-10	3525-3528	was	_	_	_	_
22-11	3529-3537	improved	_	_	_	_
22-12	3538-3551	significantly	_	_	_	_
22-13	3552-3554	by	_	_	_	_
22-14	3555-3562	surgery	event	giv	coref	25-6
22-15	3563-3566	for	_	_	_	_
22-16	3567-3570	all	person[165]	giv[165]	coref	23-1[172_165]
22-17	3571-3579	patients	person[165]	giv[165]	_	_
22-18	3580-3581	,	_	_	_	_
22-19	3582-3585	but	_	_	_	_
22-20	3586-3589	the	abstract[166]	new[166]	_	_
22-21	3590-3595	order	abstract[166]	new[166]	_	_
22-22	3596-3598	of	abstract[166]	new[166]	_	_
22-23	3599-3608	magnitude	abstract[166]|abstract	new[166]|giv	coref	26-28[216_0]
22-24	3609-3612	was	_	_	_	_
22-25	3613-3620	similar	_	_	_	_
22-26	3621-3624	for	_	_	_	_
22-27	3625-3629	both	person[169]	new[169]	_	_
22-28	3630-3633	age	abstract|person[169]	giv|new[169]	_	_
22-29	3634-3640	groups	person[169]	new[169]	_	_
22-30	3641-3642	(	_	_	_	_
22-31	3643-3644	p	abstract	new	coref	24-30
22-32	3645-3646	=	_	_	_	_
22-33	3647-3652	0.094	abstract	new	_	_
22-34	3653-3654	)	_	_	_	_
22-35	3655-3656	.	_	_	_	_

#Text=All patients demonstrated improved SF-36 PCS and MCS from baseline at the 2-year interval , with the exception of the MCS scores in the elderly group .
23-1	3657-3660	All	person[172]	giv[172]	coref	25-20[205_172]
23-2	3661-3669	patients	person[172]	giv[172]	_	_
23-3	3670-3682	demonstrated	_	_	_	_
23-4	3683-3691	improved	organization[174]|abstract[175]	new[174]|new[175]	coref|coref	24-2[0_174]|24-2[185_175]
23-5	3692-3697	SF-36	abstract|organization[174]|abstract[175]	new|new[174]|new[175]	coref	28-14
23-6	3698-3701	PCS	organization[174]|abstract[175]	new[174]|new[175]	_	_
23-7	3702-3705	and	abstract[175]	new[175]	_	_
23-8	3706-3709	MCS	abstract[175]|abstract	new[175]|new	coref	23-21
23-9	3710-3714	from	_	_	_	_
23-10	3715-3723	baseline	abstract	giv	coref	24-23
23-11	3724-3726	at	_	_	_	_
23-12	3727-3730	the	time[179]	new[179]	coref	26-16[214_179]
23-13	3731-3737	2-year	abstract|time[179]	new|new[179]	_	_
23-14	3738-3746	interval	time[179]	new[179]	_	_
23-15	3747-3748	,	_	_	_	_
23-16	3749-3753	with	_	_	_	_
23-17	3754-3757	the	abstract[180]	new[180]	_	_
23-18	3758-3767	exception	abstract[180]	new[180]	_	_
23-19	3768-3770	of	abstract[180]	new[180]	_	_
23-20	3771-3774	the	abstract[180]|abstract[182]	new[180]|giv[182]	_	_
23-21	3775-3778	MCS	abstract[180]|abstract|abstract[182]	new[180]|giv|giv[182]	coref	24-4
23-22	3779-3785	scores	abstract[180]|abstract[182]	new[180]|giv[182]	_	_
23-23	3786-3788	in	abstract[180]|abstract[182]	new[180]|giv[182]	_	_
23-24	3789-3792	the	abstract[180]|abstract[182]|person[183]	new[180]|giv[182]|giv[183]	_	_
23-25	3793-3800	elderly	abstract[180]|abstract[182]|person[183]	new[180]|giv[182]|giv[183]	_	_
23-26	3801-3806	group	abstract[180]|abstract[182]|person[183]	new[180]|giv[182]|giv[183]	_	_
23-27	3807-3808	.	_	_	_	_

#Text=Both PCS and MCS metrics echoed the functional improvement in that the younger cohort had a significantly greater degree of improvement from baseline compared to the older cohort ( p < 0.001 , p = 0.007 ) .
24-1	3809-3813	Both	abstract[187]	giv[187]	_	_
24-2	3814-3817	PCS	organization|abstract[185]|abstract[187]	giv|giv[185]|giv[187]	_	_
24-3	3818-3821	and	abstract[185]|abstract[187]	giv[185]|giv[187]	_	_
24-4	3822-3825	MCS	abstract[185]|abstract|abstract[187]	giv[185]|giv|giv[187]	_	_
24-5	3826-3833	metrics	abstract[187]	giv[187]	_	_
24-6	3834-3840	echoed	_	_	_	_
24-7	3841-3844	the	abstract[188]	giv[188]	coref	24-21[191_188]
24-8	3845-3855	functional	abstract[188]	giv[188]	_	_
24-9	3856-3867	improvement	abstract[188]	giv[188]	_	_
24-10	3868-3870	in	_	_	_	_
24-11	3871-3875	that	_	_	_	_
24-12	3876-3879	the	person[189]	giv[189]	_	_
24-13	3880-3887	younger	person[189]	giv[189]	_	_
24-14	3888-3894	cohort	person[189]	giv[189]	_	_
24-15	3895-3898	had	_	_	_	_
24-16	3899-3900	a	abstract[190]	new[190]	_	_
24-17	3901-3914	significantly	abstract[190]	new[190]	_	_
24-18	3915-3922	greater	abstract[190]	new[190]	_	_
24-19	3923-3929	degree	abstract[190]	new[190]	_	_
24-20	3930-3932	of	abstract[190]	new[190]	_	_
24-21	3933-3944	improvement	abstract[190]|abstract[191]	new[190]|giv[191]	coref	26-22[215_191]
24-22	3945-3949	from	abstract[190]|abstract[191]	new[190]|giv[191]	_	_
24-23	3950-3958	baseline	abstract[190]|abstract[191]|abstract	new[190]|giv[191]|giv	_	_
24-24	3959-3967	compared	_	_	_	_
24-25	3968-3970	to	_	_	_	_
24-26	3971-3974	the	person[193]	giv[193]	_	_
24-27	3975-3980	older	person[193]	giv[193]	_	_
24-28	3981-3987	cohort	person[193]	giv[193]	_	_
24-29	3988-3989	(	_	_	_	_
24-30	3990-3991	p	abstract	giv	coref	24-34
24-31	3992-3993	<	_	_	_	_
24-32	3994-3999	0.001	abstract	new	_	_
24-33	4000-4001	,	_	_	_	_
24-34	4002-4003	p	abstract	giv	_	_
24-35	4004-4005	=	_	_	_	_
24-36	4006-4011	0.007	abstract	new	ana	25-1
24-37	4012-4013	)	_	_	_	_
24-38	4014-4015	.	_	_	_	_

#Text=This provides good evidence that surgery leads to increased physical and mental perception of quality of life outcomes in all patients undergoing surgery for DCM .
25-1	4016-4020	This	abstract	giv	_	_
25-2	4021-4029	provides	_	_	_	_
25-3	4030-4034	good	abstract[199]	giv[199]	_	_
25-4	4035-4043	evidence	abstract[199]	giv[199]	_	_
25-5	4044-4048	that	abstract[199]	giv[199]	_	_
25-6	4049-4056	surgery	abstract[199]|event	giv[199]|giv	coref	25-23
25-7	4057-4062	leads	abstract[199]	giv[199]	_	_
25-8	4063-4065	to	abstract[199]	giv[199]	_	_
25-9	4066-4075	increased	abstract[199]|abstract[201]	giv[199]|new[201]	_	_
25-10	4076-4084	physical	abstract[199]|abstract[201]	giv[199]|new[201]	_	_
25-11	4085-4088	and	abstract[199]|abstract[201]	giv[199]|new[201]	_	_
25-12	4089-4095	mental	abstract[199]|abstract[201]	giv[199]|new[201]	_	_
25-13	4096-4106	perception	abstract[199]|abstract[201]	giv[199]|new[201]	_	_
25-14	4107-4109	of	abstract[199]|abstract[201]	giv[199]|new[201]	_	_
25-15	4110-4117	quality	abstract[199]|abstract[201]|abstract[202]|abstract[204]	giv[199]|new[201]|giv[202]|giv[204]	coref	26-10[211_202]
25-16	4118-4120	of	abstract[199]|abstract[201]|abstract[202]|abstract[204]	giv[199]|new[201]|giv[202]|giv[204]	_	_
25-17	4121-4125	life	abstract[199]|abstract[201]|abstract[202]|abstract|abstract[204]	giv[199]|new[201]|giv[202]|giv|giv[204]	coref	26-12
25-18	4126-4134	outcomes	abstract[199]|abstract[201]|abstract[204]	giv[199]|new[201]|giv[204]	_	_
25-19	4135-4137	in	abstract[199]|abstract[201]	giv[199]|new[201]	_	_
25-20	4138-4141	all	abstract[199]|abstract[201]|person[205]	giv[199]|new[201]|giv[205]	_	_
25-21	4142-4150	patients	abstract[199]|abstract[201]|person[205]	giv[199]|new[201]|giv[205]	_	_
25-22	4151-4161	undergoing	abstract[199]|abstract[201]|person[205]	giv[199]|new[201]|giv[205]	_	_
25-23	4162-4169	surgery	abstract[199]|abstract[201]|person[205]|event	giv[199]|new[201]|giv[205]|giv	_	_
25-24	4170-4173	for	abstract[199]|abstract[201]|person[205]	giv[199]|new[201]|giv[205]	_	_
25-25	4174-4177	DCM	abstract[199]|abstract[201]|person[205]|abstract	giv[199]|new[201]|giv[205]|giv	ana	26-1
25-26	4178-4179	.	_	_	_	_

#Text=It appears that older patients ’ mental perception of quality of life remains stable throughout the treatment period , despite having a worse functional improvement , and less magnitude of quality of life improvement overall .
26-1	4180-4182	It	abstract	giv	coref	27-35
26-2	4183-4190	appears	_	_	_	_
26-3	4191-4195	that	_	_	_	_
26-4	4196-4201	older	person[209]|abstract[210]	new[209]|new[210]	coref|coref	27-32[230_209]|28-6[234_210]
26-5	4202-4210	patients	person[209]|abstract[210]	new[209]|new[210]	_	_
26-6	4211-4212	’	person[209]|abstract[210]	new[209]|new[210]	_	_
26-7	4213-4219	mental	abstract[210]	new[210]	_	_
26-8	4220-4230	perception	abstract[210]	new[210]	_	_
26-9	4231-4233	of	abstract[210]	new[210]	_	_
26-10	4234-4241	quality	abstract[210]|abstract[211]	new[210]|giv[211]	coref	26-31[217_211]
26-11	4242-4244	of	abstract[210]|abstract[211]	new[210]|giv[211]	_	_
26-12	4245-4249	life	abstract[210]|abstract[211]|abstract	new[210]|giv[211]|giv	coref	26-33
26-13	4250-4257	remains	_	_	_	_
26-14	4258-4264	stable	_	_	_	_
26-15	4265-4275	throughout	_	_	_	_
26-16	4276-4279	the	time[214]	giv[214]	_	_
26-17	4280-4289	treatment	event|time[214]	new|giv[214]	_	_
26-18	4290-4296	period	time[214]	giv[214]	_	_
26-19	4297-4298	,	_	_	_	_
26-20	4299-4306	despite	_	_	_	_
26-21	4307-4313	having	_	_	_	_
26-22	4314-4315	a	abstract[215]	giv[215]	coref	26-31[219_215]
26-23	4316-4321	worse	abstract[215]	giv[215]	_	_
26-24	4322-4332	functional	abstract[215]	giv[215]	_	_
26-25	4333-4344	improvement	abstract[215]	giv[215]	_	_
26-26	4345-4346	,	_	_	_	_
26-27	4347-4350	and	_	_	_	_
26-28	4351-4355	less	abstract[216]	giv[216]	_	_
26-29	4356-4365	magnitude	abstract[216]	giv[216]	_	_
26-30	4366-4368	of	abstract[216]	giv[216]	_	_
26-31	4369-4376	quality	abstract[216]|abstract[217]|abstract[219]	giv[216]|giv[217]|giv[219]	coref	27-11[222_217]
26-32	4377-4379	of	abstract[216]|abstract[217]|abstract[219]	giv[216]|giv[217]|giv[219]	_	_
26-33	4380-4384	life	abstract[216]|abstract[217]|abstract|abstract[219]	giv[216]|giv[217]|giv|giv[219]	coref	27-13
26-34	4385-4396	improvement	abstract[216]|abstract[219]	giv[216]|giv[219]	_	_
26-35	4397-4404	overall	abstract[216]|abstract[219]	giv[216]|giv[219]	_	_
26-36	4405-4406	.	_	_	_	_

#Text=This study is the first to report this difference in quality of life measures between younger and older aged cohorts and has potentially large implications on pre-surgical assessment and counselling in older patients with DCM .
27-1	4407-4411	This	abstract[220]	giv[220]	coref	30-26[260_220]
27-2	4412-4417	study	abstract[220]	giv[220]	_	_
27-3	4418-4420	is	_	_	_	_
27-4	4421-4424	the	_	_	_	_
27-5	4425-4430	first	_	_	_	_
27-6	4431-4433	to	_	_	_	_
27-7	4434-4440	report	_	_	_	_
27-8	4441-4445	this	abstract[221]	new[221]	_	_
27-9	4446-4456	difference	abstract[221]	new[221]	_	_
27-10	4457-4459	in	abstract[221]	new[221]	_	_
27-11	4460-4467	quality	abstract[221]|abstract[222]|abstract[224]	new[221]|giv[222]|new[224]	coref|coref	29-13[247_222]|30-10[256_224]
27-12	4468-4470	of	abstract[221]|abstract[222]|abstract[224]	new[221]|giv[222]|new[224]	_	_
27-13	4471-4475	life	abstract[221]|abstract[222]|abstract|abstract[224]	new[221]|giv[222]|giv|new[224]	coref	28-37
27-14	4476-4484	measures	abstract[221]|abstract[224]	new[221]|new[224]	_	_
27-15	4485-4492	between	abstract[221]	new[221]	_	_
27-16	4493-4500	younger	abstract[221]|person[225]	new[221]|new[225]	_	_
27-17	4501-4504	and	abstract[221]|person[225]	new[221]|new[225]	_	_
27-18	4505-4510	older	abstract[221]|person[225]	new[221]|new[225]	_	_
27-19	4511-4515	aged	abstract[221]|person[225]	new[221]|new[225]	_	_
27-20	4516-4523	cohorts	abstract[221]|person[225]	new[221]|new[225]	_	_
27-21	4524-4527	and	_	_	_	_
27-22	4528-4531	has	_	_	_	_
27-23	4532-4543	potentially	abstract[226]	new[226]	_	_
27-24	4544-4549	large	abstract[226]	new[226]	_	_
27-25	4550-4562	implications	abstract[226]	new[226]	_	_
27-26	4563-4565	on	abstract[226]	new[226]	_	_
27-27	4566-4578	pre-surgical	abstract[226]|abstract[227]|abstract[228]	new[226]|giv[227]|giv[228]	coref	30-11[0_227]
27-28	4579-4589	assessment	abstract[226]|abstract[227]|abstract[228]	new[226]|giv[227]|giv[228]	_	_
27-29	4590-4593	and	abstract[226]|abstract[228]	new[226]|giv[228]	_	_
27-30	4594-4605	counselling	abstract[226]|abstract[228]|abstract[229]	new[226]|giv[228]|new[229]	_	_
27-31	4606-4608	in	abstract[226]|abstract[228]|abstract[229]	new[226]|giv[228]|new[229]	_	_
27-32	4609-4614	older	abstract[226]|abstract[228]|abstract[229]|person[230]	new[226]|giv[228]|new[229]|giv[230]	_	_
27-33	4615-4623	patients	abstract[226]|abstract[228]|abstract[229]|person[230]	new[226]|giv[228]|new[229]|giv[230]	_	_
27-34	4624-4628	with	abstract[226]|abstract[228]|abstract[229]|person[230]	new[226]|giv[228]|new[229]|giv[230]	_	_
27-35	4629-4632	DCM	abstract[226]|abstract[228]|abstract[229]|person[230]|abstract	new[226]|giv[228]|new[229]|giv[230]|giv	coref	30-14[257_0]
27-36	4633-4634	.	_	_	_	_

#Text=However , age-related effects on health perception have been found to influence the SF-36 score , and the contribution from the perception of physical effects often misses a number of important determinants of overall quality of life in older persons .
28-1	4635-4642	However	_	_	_	_
28-2	4643-4644	,	_	_	_	_
28-3	4645-4656	age-related	abstract[232]	giv[232]	coref	28-24[239_232]
28-4	4657-4664	effects	abstract[232]	giv[232]	_	_
28-5	4665-4667	on	abstract[232]	giv[232]	_	_
28-6	4668-4674	health	abstract[232]|abstract|abstract[234]	giv[232]|new|giv[234]	_	_
28-7	4675-4685	perception	abstract[232]|abstract[234]	giv[232]|giv[234]	_	_
28-8	4686-4690	have	_	_	_	_
28-9	4691-4695	been	_	_	_	_
28-10	4696-4701	found	_	_	_	_
28-11	4702-4704	to	_	_	_	_
28-12	4705-4714	influence	_	_	_	_
28-13	4715-4718	the	abstract[236]	new[236]	_	_
28-14	4719-4724	SF-36	abstract|abstract[236]	giv|new[236]	_	_
28-15	4725-4730	score	abstract[236]	new[236]	_	_
28-16	4731-4732	,	_	_	_	_
28-17	4733-4736	and	_	_	_	_
28-18	4737-4740	the	abstract[237]	new[237]	_	_
28-19	4741-4753	contribution	abstract[237]	new[237]	_	_
28-20	4754-4758	from	abstract[237]	new[237]	_	_
28-21	4759-4762	the	abstract[237]|abstract[238]	new[237]|new[238]	_	_
28-22	4763-4773	perception	abstract[237]|abstract[238]	new[237]|new[238]	_	_
28-23	4774-4776	of	abstract[237]|abstract[238]	new[237]|new[238]	_	_
28-24	4777-4785	physical	abstract[237]|abstract[238]|abstract[239]	new[237]|new[238]|giv[239]	_	_
28-25	4786-4793	effects	abstract[237]|abstract[238]|abstract[239]	new[237]|new[238]|giv[239]	_	_
28-26	4794-4799	often	_	_	_	_
28-27	4800-4806	misses	_	_	_	_
28-28	4807-4808	a	abstract[240]	new[240]	coref	29-13[249_240]
28-29	4809-4815	number	abstract[240]	new[240]	_	_
28-30	4816-4818	of	abstract[240]	new[240]	_	_
28-31	4819-4828	important	abstract[240]	new[240]	_	_
28-32	4829-4841	determinants	abstract[240]	new[240]	_	_
28-33	4842-4844	of	abstract[240]	new[240]	_	_
28-34	4845-4852	overall	abstract[240]|abstract[241]	new[240]|new[241]	ana	29-5[0_241]
28-35	4853-4860	quality	abstract[240]|abstract[241]	new[240]|new[241]	_	_
28-36	4861-4863	of	abstract[240]|abstract[241]	new[240]|new[241]	_	_
28-37	4864-4868	life	abstract[240]|abstract[241]|abstract	new[240]|new[241]|giv	coref	29-15
28-38	4869-4871	in	abstract[240]|abstract[241]	new[240]|new[241]	_	_
28-39	4872-4877	older	abstract[240]|abstract[241]|person[243]	new[240]|new[241]|new[243]	_	_
28-40	4878-4885	persons	abstract[240]|abstract[241]|person[243]	new[240]|new[241]|new[243]	_	_
28-41	4886-4887	.	_	_	_	_

#Text=For these reasons , it has been suggested that the focus of quality of life determinants in the elderly should be weighted toward mental components rather than the physical .
29-1	4888-4891	For	_	_	_	_
29-2	4892-4897	these	abstract[244]	new[244]	_	_
29-3	4898-4905	reasons	abstract[244]	new[244]	_	_
29-4	4906-4907	,	_	_	_	_
29-5	4908-4910	it	abstract	giv	_	_
29-6	4911-4914	has	_	_	_	_
29-7	4915-4919	been	_	_	_	_
29-8	4920-4929	suggested	_	_	_	_
29-9	4930-4934	that	_	_	_	_
29-10	4935-4938	the	abstract[246]	new[246]	ana	30-1[0_246]
29-11	4939-4944	focus	abstract[246]	new[246]	_	_
29-12	4945-4947	of	abstract[246]	new[246]	_	_
29-13	4948-4955	quality	abstract[246]|abstract[247]|abstract[249]	new[246]|giv[247]|giv[249]	_	_
29-14	4956-4958	of	abstract[246]|abstract[247]|abstract[249]	new[246]|giv[247]|giv[249]	_	_
29-15	4959-4963	life	abstract[246]|abstract[247]|abstract|abstract[249]	new[246]|giv[247]|giv|giv[249]	_	_
29-16	4964-4976	determinants	abstract[246]|abstract[249]	new[246]|giv[249]	_	_
29-17	4977-4979	in	abstract[246]|abstract[249]	new[246]|giv[249]	_	_
29-18	4980-4983	the	abstract[246]|abstract[249]|person[250]	new[246]|giv[249]|new[250]	_	_
29-19	4984-4991	elderly	abstract[246]|abstract[249]|person[250]	new[246]|giv[249]|new[250]	_	_
29-20	4992-4998	should	_	_	_	_
29-21	4999-5001	be	_	_	_	_
29-22	5002-5010	weighted	_	_	_	_
29-23	5011-5017	toward	_	_	_	_
29-24	5018-5024	mental	abstract[251]	new[251]	_	_
29-25	5025-5035	components	abstract[251]	new[251]	_	_
29-26	5036-5042	rather	_	_	_	_
29-27	5043-5047	than	_	_	_	_
29-28	5048-5051	the	_	_	_	_
29-29	5052-5060	physical	_	_	_	_
29-30	5061-5062	.	_	_	_	_

#Text=This also raises certain questions about the efficacy of functional assessment measures for DCM in the elderly , but this was beyond the scope of the current study .
30-1	5063-5067	This	abstract	giv	ana	30-20
30-2	5068-5072	also	_	_	_	_
30-3	5073-5079	raises	_	_	_	_
30-4	5080-5087	certain	abstract[253]	new[253]	_	_
30-5	5088-5097	questions	abstract[253]	new[253]	_	_
30-6	5098-5103	about	abstract[253]	new[253]	_	_
30-7	5104-5107	the	abstract[253]|abstract[254]	new[253]|new[254]	_	_
30-8	5108-5116	efficacy	abstract[253]|abstract[254]	new[253]|new[254]	_	_
30-9	5117-5119	of	abstract[253]|abstract[254]	new[253]|new[254]	_	_
30-10	5120-5130	functional	abstract[253]|abstract[254]|abstract[256]	new[253]|new[254]|giv[256]	_	_
30-11	5131-5141	assessment	abstract[253]|abstract[254]|abstract|abstract[256]	new[253]|new[254]|giv|giv[256]	_	_
30-12	5142-5150	measures	abstract[253]|abstract[254]|abstract[256]	new[253]|new[254]|giv[256]	_	_
30-13	5151-5154	for	abstract[253]|abstract[254]|abstract[256]	new[253]|new[254]|giv[256]	_	_
30-14	5155-5158	DCM	abstract[253]|abstract[254]|abstract[256]|abstract[257]	new[253]|new[254]|giv[256]|giv[257]	_	_
30-15	5159-5161	in	abstract[253]|abstract[254]|abstract[256]|abstract[257]	new[253]|new[254]|giv[256]|giv[257]	_	_
30-16	5162-5165	the	abstract[253]|abstract[254]|abstract[256]|abstract[257]	new[253]|new[254]|giv[256]|giv[257]	_	_
30-17	5166-5173	elderly	abstract[253]|abstract[254]|abstract[256]|abstract[257]	new[253]|new[254]|giv[256]|giv[257]	_	_
30-18	5174-5175	,	_	_	_	_
30-19	5176-5179	but	_	_	_	_
30-20	5180-5184	this	abstract	giv	_	_
30-21	5185-5188	was	_	_	_	_
30-22	5189-5195	beyond	_	_	_	_
30-23	5196-5199	the	abstract[259]	new[259]	_	_
30-24	5200-5205	scope	abstract[259]	new[259]	_	_
30-25	5206-5208	of	abstract[259]	new[259]	_	_
30-26	5209-5212	the	abstract[259]|abstract[260]	new[259]|giv[260]	_	_
30-27	5213-5220	current	abstract[259]|abstract[260]	new[259]|giv[260]	_	_
30-28	5221-5226	study	abstract[259]|abstract[260]	new[259]|giv[260]	_	_
30-29	5227-5228	.	_	_	_	_
